European Archives - Page 224 of 1370 - European Medical Journal

Combination Therapy Improves Survival in Liver Cancer

Results showed that patients receiving the combination therapy experienced a median progression-free survival of 5.8 months, compared with 4.0 months.

Edoxaban Suitable for Stroke Prevention in Over-75s with AF?

Edoxaban and rivaroxaban show best balance of efficacy and safety in elderly patients with atrial fibrillation.

Could a Plant-Based Diet Shield Against Early Neurodegeneration?

Eating more healthful plant-based foods may help protect eye and nerve health, new research shows, with retinal imaging revealing early signs of neuroprotection.

EHA 2025: CONCEPT Trial Shows Isatuximab Benefits High-Risk Myeloma

The Phase II CONCEPT trial has demonstrated that an isatuximab-based combination therapy achieves unprecedented rates of minimal residual disease negativity in patients with high-risk newly diagnosed multiple myeloma.

Mediterranean Diet Linked to Milder Crohn’s Disease and Healthier Gut Profile

A prospective study has found that the Mediterranean diet may help reduce inflammation and support a healthier gut microbiome in newly diagnosed Crohn’s disease patients.

Azithromycin Resistance in Gonorrhoea Surges Across Europe

Azithromycin resistance in gonorrhoea has surged across Europe, underscoring the urgent need for enhanced surveillance and new treatment options.

What HCPs want: Why interactive medical content works

Explore how interactive medical content empowers today’s HCPs to access the information they need in a faster, easier and more engaging way.

New AI-Powered Model Improves Skin Disease Diagnosis

The model integrates four key types of imagery: total-body photographs, standard clinical photos, dermoscopic close-ups, and dermatopathology slides.

Bridging Borders in Women’s Health

This week, the host Saranya Ravindran welcomes Tommaso Falcone, reproductive health pioneer and global healthcare leader. From redefining…

Two Decades On, Atrial Fibrillation Outcomes Show Uneven Progress

Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks remain unchanged.